Transforming Companion Animal Health

 

Poïesis Therapeutics is a biotechnology start-up focused on sourcing and in-licensing innovative late stage therapeutics and diagnostics from human biomedical research and developing them to address unmet needs in the veterinary market for pets – dogs, cats and horses.

 

One World.
One Medicine.
One Health.

 

Our mission statement adheres to the “one health” concept, reflective of the inherent synergies between animal and human medicine.

 

Therapeutics

Developing new medicines to address unmet needs in animal health.

Diagnostics

Developing new veterinary diagnostics to identify disorders in dogs, cats and horses.

Corporate Social Responsibility

Poïesis contributes a percentage of its profits to chosen charities which are making a difference for humans and animals.

Latest News

Three Trends That Will Transform Animal Health

By Michael Helmstetter, Ph.D., President and CEO, TechAccel, July 27, 2017.  Many investors who are interested in the animal health space still feel they don’t know the industry well enough to make smart investments. The feeling is understandable. Animal health is an...

read more

Why Pet Health Is The Focus Of A New Biotech Sector

By Cathy Yarbrough, Contributing Editor   For Aratana Therapeutics, 2016 was a banner year. The biotech company, founded in 2010, achieved FDA approvals for three of its 10 pipeline drugs. Last year the Kansas City-based company also forged a global partnership with...

read more

PRESS RELEASES

 

.